Target Dividend Double Play Portfolio, 4th Quarter 2024
Ticker Symbol: FQGEUX

Holdings (As of Day of Deposit)
Ticker Company Name Initial
Weight
Price*
Target High Quality Dividend Strategy Stocks
ADM Archer-Daniels-Midland Company 1.67% $57.55
CNQ Canadian Natural Resources Limited 1.67% 36.36
CVX Chevron Corporation 1.69% 148.75
CMCSA Comcast Corporation 1.68% 40.95
CFR Cullen/Frost Bankers, Inc. 1.65% 113.46
CVS CVS Health Corporation 1.66% 65.90
EMN Eastman Chemical Company 1.64% 108.27
XOM Exxon Mobil Corporation 1.69% 122.04
FNF Fidelity National Financial, Inc. 1.67% 60.17
FITB Fifth Third Bancorp 1.67% 41.99
GPC Genuine Parts Company 1.69% 133.67
DINO HF Sinclair Corp. 1.66% 44.51
HPQ HP Inc. 1.66% 36.00
IPG The Interpublic Group of Companies, Inc. 1.67% 30.87
LKQ LKQ Corporation 1.66% 38.22
MOS The Mosaic Company 1.66% 25.81
MUR Murphy Oil Corporation 1.67% 34.78
NTR Nutrien Ltd. 1.65% 48.57
PSX Phillips 66 1.67% 132.33
PNC The PNC Financial Services Group, Inc. 1.71% 180.86
PFG Principal Financial Group, Inc. 1.68% 85.87
PB Prosperity Bancshares, Inc. 1.69% 70.33
RF Regions Financial Corporation 1.66% 22.74
RHI Robert Half Inc. 1.69% 66.79
STT State Street Corporation 1.68% 88.57
SU Suncor Energy Inc. 1.66% 39.28
SNV Synovus Financial Corp. 1.66% 43.05
TPR Tapestry, Inc. 1.66% 45.26
TGT Target Corporation 1.62% 151.32
TSN Tyson Foods, Inc. 1.65% 58.29
S&P Dividend Aristocrats Target 25 Strategy Stocks
AOS A.O. Smith Corporation 2.02% 86.45
AFL Aflac Incorporated 1.99% 112.47
ADM Archer-Daniels-Midland Company 2.00% 57.55
BF/B Brown-Forman Corporation 2.00% 46.60
CAT Caterpillar Inc. 1.96% 387.96
CVX Chevron Corporation 1.97% 148.75
CB Chubb Limited 1.94% 279.96
CINF Cincinnati Financial Corporation 2.03% 133.88
DOV Dover Corporation 2.01% 187.16
EXPD Expeditors International of Washington, Inc. 1.99% 121.41
XOM Exxon Mobil Corporation 2.00% 122.04
FAST Fastenal Company 1.99% 70.17
BEN Franklin Resources, Inc. 2.00% 19.35
GD General Dynamics Corporation 2.06% 296.90
GPC Genuine Parts Company 2.02% 133.67
HRL Hormel Foods Corporation 2.00% 31.07
JNJ Johnson & Johnson 2.01% 159.69
KMB Kimberly-Clark Corporation 1.97% 142.01
LIN Linde Plc 2.07% 469.44
NUE Nucor Corporation 1.96% 148.11
PG The Procter & Gamble Company 2.01% 168.16
TROW T. Rowe Price Group, Inc. 2.02% 106.60
TGT Target Corporation 2.00% 151.32
GWW W.W. Grainger, Inc. 1.95% 1,028.56
WST West Pharmaceutical Services, Inc. 1.99% 286.48

*As of the close of business on 10/8/24. Market values are for reference only and are not indicative of your individual cost basis. Holdings were selected by applying each strategy as described in the prospectus.


Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Offering Date 10/10/2024
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 1/9/2026
Historical 12-Month Distribution Rate of Trust Holdings* 2.58%
Historical 12-Month Distribution Per Unit* $0.2582
Cash CUSIP 30337N787
Reinvestment CUSIP 30337N795
Fee Accounts Cash CUSIP 30337N803
Fee Accounts Reinvestment CUSIP 30337N811

*There is no guarantee the issuers of the securities included in the trust will declare dividends or distributions in the future. The historical 12-month distribution per unit and historical 12-month distribution rate of the securities included in the trust are for illustrative purposes only and are not indicative of the trust’s distribution or distribution rate. The historical 12-month distribution per unit is based on the weighted average of the trailing 12-month distributions paid by the securities included in the portfolio. The historical 12-month distribution rate is calculated by dividing the historical 12-month distributions by the trust’s offering price. The historical 12-month distribution and rate are reduced to account for the effects of fees and expenses, which will be incurred when investing in a trust. Certain of the issuers may have reduced their dividends or distributions over the prior 12 months. The distribution per unit and rate paid by the trust may be higher or lower than the amount shown above due to certain factors that may include, but are not limited to, a change in the dividends or distributions paid by issuers, actual expenses incurred, or the sale of securities in the portfolio.


Fee Table (based on a $10 public offering price per unit)
  Standard Fee/Wrap
Deferred Sales Charge 1.35%
Creation & Development Fee (C&D Fee) 0.50% 0.50%
Maximum Sales Charge 1.85% 0.50%
     
Estimated Organization Costs 0.500% 0.500%
Estimated Annual Trust Operating Expenses 0.195% 0.195%

The deferred sales charge will be deducted in three monthly installments commencing 1/17/25. When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge. The C&D fee is a charge of $0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10.00 per unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10.00 per unit, the C&D fee will exceed 0.50%. Estimated organization costs will be deducted from the assets of the trust at the end of the initial offering period. Estimated organization costs and trust operating expenses are assessed on a fixed dollar amount per unit basis which, as a percentage of average net assets, will vary over time. Actual expenses may be more or less than the estimates. Please see “Fee Table” in the trust prospectus for additional information.

You should consider the portfolio's investment objectives, risks, and charges and expenses carefully before investing. Contact your financial professional or call First Trust Portfolios, L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations

An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

You should be aware that the portfolio is concentrated in stocks in the financials sector which involves additional risks, including limited diversification. The companies engaged in the financials sector are subject to the adverse effects of volatile interest rates, economic recession, decreases in the availability of capital, increased competition from new entrants in the field, and potential increased regulation.

Securities of non-U.S. issuers are subject to additional risks, including currency fluctuations, political risks, withholding, the lack of adequate financial information, and exchange control restrictions impacting non-U.S. issuers.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Large capitalization companies may grow at a slower rate than the overall market.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

Ongoing armed conflicts between Russia and Ukraine in Europe and among Israel, Hamas and other militant groups in the Middle East, have caused and could continue to cause significant market disruptions and volatility within the markets in Russia, Europe, the Middle East and the United States. The hostilities and sanctions resulting from those hostilities could have a significant impact on certain investments as well as performance.

The ongoing effects of the COVID-19 global pandemic, or the potential impacts of any future public health crisis, may cause significant volatility and uncertainty in global financial markets. While vaccines have been developed, there is no guarantee that vaccines will be effective against future variants of the disease.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

This UIT is a buy and hold strategy and investors should consider their ability to hold the trust until maturity. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

The S&P 500 Dividend Aristocrats Index is a product of S&P Dow Jones Indices LLC or its affiliates (“SPDJI”) and has been licensed for use by First Trust Portfolios L.P. Standard & Poor’s® and S&P® are registered trademarks of Standard & Poor’s Financial Services LLC (“S&P”); Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC (“Dow Jones”); and these trademarks have been licensed for use by SPDJI and sublicensed for certain purposes by First Trust Portfolios L.P. The Target Dividend Double Play Portfolio, which contains the S&P Dividend Aristocrats Target 25 Strategy, is not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates, and none of such parties make any representation regarding the advisability of investing in such product nor do they have any liability for any errors, omissions, or interruptions of the S&P 500 Dividend Aristocrats Index.

 

CUSIP identifiers have been provided by CUSIP Global Services, managed on behalf of the American Bankers Association by FactSet Research Systems Inc. and are not for use or dissemination in a manner that would serve as a substitute for any CUSIP service. The CUSIP Database, ©2024 CUSIP Global Services. "CUSIP" is a registered trademark of the American Bankers Association.